Completed PHASE4 INTERVENTIONAL 2-arm NCT00228384

GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study

GORE VIABAHN Endoprosthesis Versus Bare Nitinol Stent in the Treatment of Long Lesion (>8cm) Superficial Femoral Artery Occlusive Disease

Sponsor: W.L.Gore & Associates

Conditions Peripheral Vascular Diseases

Interventions Bare Nitinol Stent GORE VIABAHN Endoprosthesis

Updated 7 times since 2017 Last updated: May 25, 2012 Started: Sep 30, 2005 Primary completion: Jan 31, 2011 Completion: Jan 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Peripheral Vascular Diseases and is currently completed. W.L.Gore & Associates leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

W.L.Gore & Associates

Data source: W.L.Gore & Associates

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Austell, United States , Beaver, United States , Cleveland, United States , Columbus, United States , Fort Lauderdale, United States , Little Rock, United States , Lombard, United States , Melrose Park, United States , Milwaukee, United States , New Orleans, United States and 5 more locations